Ca2+ signalling in endothelial progenitor cells: A novel means to improve cell-based therapy and impair tumour vascularisation

Current Vascular Pharmacology

Volumn 12, Issue 1, 2014, Pages 87-105

  Moccia, Francesco ^a   Lodola, Francesco ^a   Dragoni, Silvia ^a   Bonetti, Elisa ^b   Bottino, Cinzia ^a   Guerra, Germano ^c   Laforenza, Umberto ^a   Rosti, Vittorio ^b   Tanzi, Franco ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF MOLISE   (Italy)

Author keywords

Cell therapy; Endothelial progenitor cells; Orail Stim1; Tumor vascularization

Indexed keywords

ASCORBIC ACID; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; BEVACIZUMAB; CALCIUM ION; CD133 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; EPIDERMAL GROWTH FACTOR; FIBRONECTIN; G PROTEIN COUPLED RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; HEPARIN; HYDROCORTISONE; HYPOXIA INDUCIBLE FACTOR 1; INOSITOL 1,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHOLIPASE C; PROTEIN KINASE B; SOMATOMEDIN; SORAFENIB; SUNITINIB; TYROSINE KINASE RECEPTOR; UNINDEXED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR; CALCIUM; CALCIUM CHANNEL; MEMBRANE PROTEIN; ORAI1 PROTEIN, HUMAN; STIM1 PROTEIN, HUMAN; TUMOR PROTEIN;

ACUTE HEART INFARCTION; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL CYCLE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CELL THERAPY; COLONY FORMING CELL; COLONY FORMING UNIT; ENDOTHELIAL PROGENITOR CELL; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENETIC MANIPULATION; HUMAN; NONHUMAN; OSTEOCLASTOGENESIS; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; CALCIUM SIGNALING; CELL MOTION; ENDOTHELIUM CELL; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION;

ANIMALS; CALCIUM; CALCIUM CHANNELS; CALCIUM SIGNALING; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; HUMANS; MEMBRANE PROTEINS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84897453981     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/157016111201140327162858     Document Type: Article

References (182)

1. Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747-57.
2. Seiler C. The human coronary collateral circulation. Heart 2003; 89: 1352-7.
3. 2+signalling in damaged endothelium: do connexin hemichannels aid in filling the gap? Curr Drug Ther 2010; 5: 277-87.
4. Kawamoto A, Asahara T. Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies. Catheter Cardiovasc Inter 2007; 70: 477-84.
5. Krenning G, van Luyn MJ, Harmsen MC. Endothelial progenitor cell-based neovascularization: implications for therapy. Trends Mol Med 2009; 15: 180-9.
6. Passier R, van Laake LW, Mummery CL. Stem-cell-based therapy and lessons from the heart. Nature 2008; 453: 322-9.
7. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003; 9: 702-12.
8. Asahara T. Cell therapy and gene therapy using endothelial progenitor cells for vascular regeneration. Handb Exp Pharmacol 2007; 180: 181-94.
9. Ben-Shoshan J, George J. Endothelial progenitor cells as therapeutic vectors in cardiovascular disorders: from experimental models to human trials. Pharmacol Ther 2007; 115: 25-36.
10. Pompilio G, Capogrossi MC, Pesce M, et al. Endothelial progenitor cells and cardiovascular homeostasis: clinical implications. Int J Cardiol 2009; 131: 156-67.
11. Gao D, Nolan DJ, Mellick AS, et al. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 2008; 319: 195-8.
12. Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011; 473: 298-307.
13. Gao DC, Nolan D, McDonnell K, et al. Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression. Biochim Biophys Acta 2009; 1796: 33-40.
14. Nolan DJ, Ciarrocchi A, Mellick AS, et al. Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev 2007; 21: 1546-58.
15. Shaked Y, Henke E, Roodhart JM, et al. Rapid chemotherapyinduced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents. Cancer Cell 2008; 14: 263-73.
16. Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 2003; 4: 517-29.
17. Clapham DE. Calcium signaling. Cell 2007; 131: 1047-58.
18. 2+signalling. FEBS J 2009; 276: 1800-16.
19. Munaron L. Intracellular calcium, endothelial cells and angiogenesis. Recent Pat Anticancer Drug Discov 2006; 1: 105-19.
20. Florio Pla A, Avanzato D, Munaron L, Ambudkar IS. Vascularizing the tumor: TRP channels as molecular targets. Am J Physiol Cell Physiol 2011; 302:C9-15.
21. Munaron L, Fiorio Pla A. Endothelial calcium machinery and angiogenesis: understanding physiology to interfere with pathology. Curr Med Chem 2009; 16: 4691-703.
22. Critser PJ, Yoder MC. Endothelial colony-forming cell role in neoangiogenesis and tissue repair. Curr Opin Organ Transplant 2010; 1: 68-72.
23. Fischer C, Schneider M, Carmeliet P. Principles and therapeutic implications of angiogenesis, vasculogenesis and arteriogenesis. Handb Exp Pharmacol 2006; 176: 157-212.
24. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004; 95: 343-53.
25. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 2759: 964-7.
26. Critser PJ, Voytik-Harbin SL, Yoder MC. Isolating and defining cells to engineer human blood vessels. Cell Prolif 2011; 44: 15-21.
27. Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008; 28: 1584-95.
28. Richardson MR, Yoder MC. Endothelial progenitor cells: quo vadis? J Mol Cell Cardiol 2011; 50: 266-72.
29. Yoder MC, Mead LE, Prater D, et al. Re-defining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007; 109: 1801-9.
30. Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000; 97: 3422-7.
31. Ingram DA, Mead LE, Tanaka H, et al. Identification of a novel hyerarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004; 104: 2752-60.
32. Prater DN, Case J, Ingram D, Yoder MC. Working hypothesis to redefine endothelial progenitor cells. Leukemia 2007; 21: 1141-9.
33. Schechner JS, Nath AK, Zheng L, et al. In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. Proc Natl Acad Sci USA 2000; 97: 9191-6.
34. Zambelli A, Della Porta M, Rosti V. From cancer patients to cancer survivors: the issue of cardioncology. Eur J Cancer 2010;46: 697-702.
35. Leone M, Rutella S, Bonanno G, et al. Mobilization of bone marrow derived stem cells after myocardial infarction and left ventricular function. Eur Heart J 2005; 26:1196-204.
36. Massa M, Rosti V, Ferrario M, et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2005; 105:199-206.
37. Massa M, Campanelli R, Bonetti E, et al. Rapid and large increase of the frequency of circulating endothelial colony forming cells (ECFCs) generating late outgrowth endothelial cells in patients with acute myocardial infarction. Exp Hematol 2009; 37: 8-9.
38. Shintani S, Murohara T, Ikeda H, et al. Mobilization of endothelial progenitor cells in patients wth acute myocardial infarction. Circulation 2001; 103: 2776-9.
39. +stem cells is correlated with left ventricular ejection fraction and plasma NT-proBNP levels in patients wirth acure myocardial infarction. Eur Heart J 2006; 27:283-9.
40. Kunz GA, Liang G, Kukuloski F, et al. Circulating endothelial progenitor cells predict coronary artery disease severity. Am Heart J 2006; 152: 190-5.
41. Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999-1007.
42. Guven H, Shepherd RM, Bach RG, Capoccia BJ, Link DC. The number of EPC colonies in the blood is increased in patients with angiographically significant coronary artery disease. J Am Coll Cardiol 2006; 48: 1579-87.
43. +endothelial precursor cells. Circ Res 2001; 88: 167-74.
44. Fox A, Smythe J, Fisher N, et al. Mobilization of endothelial progenitor cells into the circulation in burned patients. Br J Surg 2008; 95: 244-51.
45. Lawall H, Bramlage P, Amann B. Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal. Thromb Haemost 2010; 103: 696-709.
46. Germani A, Di Campli C, Pompilio G, et al. Regenerative therapy in peripheral artery disease. Cardiovasc Ther 2009; 27: 289-304.
47. Murasawa S, Asahara T. Endothelial progenitor cells for vasculogenesis. Physiology 2005; 20: 36-42.
48. Zampetaki A, Kirton JP, Xu Q. Vascular repair by endothelial progenitor cells. Cardiovasc Res 2008; 78: 413-21.
49. Liu P, Zhou B, Gu D, Zhang L, Han Z. Endothelial progenitor cell therapy in atherosclerosis: a double-edged sword? Ageing Res Rev 2009; 8: 83-93.
50. Tepper OM, Galiano RD, Capla JM, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002; 106: 2781-6.
51. Penn MS, Mangi AA. Genetic enhancement of stem cell engraftment, survival, and efficacy. Circ Res 2008; 102: 1471-82.
52. Chavakis E, Urbich C, Dimmeler S. Homing and engraftment of progenitor cells: a prerequisite for cell therapy. J Mol Cell Cardiol 2008; 45: 514-22.
53. Sieveking DP, Ng MK. Cell therapies for therapeutic angiogenesis: back to the bench. Vasc Med 2009; 14: 153-66.
54. Hanahan D, Folkman J. Pattern and emerging mechanism of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-64.
55. Kaplan RN, Riba RD, Zacharoulis S, et al. VEGFR-1 positive hematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005; 438: 820-7.
56. Lyden D, Hattori K, Dias S, et al. Impaired recruitment of bone marrow-derived endothelial and hematopoietic precursors blocks tumor angiogenesis and growth. Nat Med 2001; 7: 1194-201.
57. Coghlin C, Murray GI. Current and emerging concepts in tumor metastasis. J Pathol 2010; 222: 1-15.
58. Peters BA, Diaz LA, Polyak K, et al. Contribution of bone marrowderived endothelial cells to human tumor vasculature. Nat Med 2005; 11: 261-2.
59. Li Calzi S, Neu MB, Shaw LC, Kielczewski JL, Moldovan NI, Grant MB. EPCs and pathological angiogenesis: when good cells go bad. Microv Res 2010; 79: 207-16.
60. Young PP, Vaughan DE, Hatzopoulos AK. Biologic properties of endothelial progenitor cells and their potential for cell therapy. Prog Cardiovasc Dis 2007; 49: 421-9.
61. Ellis LM, Hicklin DJ. Pathways mediating resistance to vascular endothelial growth factor-targeted therapy. Clin Cancer Res 2008; 14: 6371-5.
62. Bergers G, Hananah D. Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 2008; 8: 592-603.
63. 2+oscillations in microvascular endothelial cells. J Cell Physiol 2003; 194: 139-50.
64. Pal S, Wu J, Murray JK, et al. An antiangiogenic neurokinin-B/thromboxane A2 regulatory axis. J Cell Biol 2006; 174: 1047-58.
65. 2+oscillations. Trends Biochem Sci 2011; 36: 78-87.
66. 2+oscillations in human cerebrovascular endothelial cells after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2009; 29: 57-65.
67. Tran QK, Watanabe H. Calcium signalling in the endothelium. Handb Exp Pharmacol. 2006; 176: 145-87.
68. 2+-ATPase in rat microvascular endothelial cells. Biochem J 2002; 364: 235-44.
69. 2+-ATPase and inositol 1,4,5-trisphosphate receptor isoforms in vascular endothelial cells. Cell Calcium 1999; 25: 371-80.
70. 2+release channels. Physiol Rev 2007; 87: 593-658.
71. Abdullaev IF, Bisaillon JM, Potier M, Gonzalez JC, Motiani RK, Trebak M. Stim1 and Orai1 mediate CRAC currents and storeoperated calcium entry important for endothelial cell proliferation. Circ Res 2008; 103: 1289-99.
72. Banumathi E, O'Connor A, Gurunathan S, Simpson DA, McGeown JG, Curtis TM. VEGF-induced retinal angiogenic signaling is critically dependent on Ca2+ signaling by Ca2+/calmodulin-dependent protein kinase II. Invest Ophthalmol Vis Sci 2011; 52: 3103-11.
73. Faehling M, Kroll J, Föhr KJ, et al. Essential role of calcium in vascular endothelial growth factor A-induced signaling: mechanism of the antiangiogenic effect of carboxyamidotriazole. FASEB J 2002; 16: 1805-7.
74. 2+entry and endothelial tube formation. Circ Res 2011; 108: 1190-8.
75. Rinne A, Banach K, Blatter LA. Regulation of nuclear factor of activated T cells (NFAT) in vascular endothelial cells. J Mol Cell Cardiol 2009; 47: 400-10.
76. 2+waves sneaking under the plasma membrane in endothelial cells. Circ Res 2004; 95: e11-21.
77. 2+signaling, TRP channels, and endothelial permeability. Microcirculation 2006; 13: 693-708.
78. Parekh AB. Store-operated CRAC channels: function in health and disease. Nat Rev Drug Discov 2010; 9: 399-410.
79. Smyth JT, Hwang SY, Tomita T, DeHaven WI, Mercer JC, Putney JW. Activation and regulation of store-operated calcium entry. J Cell Mol Med 2010; 14: 2337-49.
80. Hogan PG, Lewis RS, Rao A. Molecular basis of calcium signaling in lymphocytes: STIM and ORAI. Annu Rev Immunol 2010; 28: 491-533.
81. 2+levels. Cell 2007; 131: 1327-39.
82. Fasolato C, Nilius B. Store depletion triggers the calcium releaseactivated calcium current (ICRAC) in macrovascular endothelial cells: a comparison with Jurkat and embryonic kidney cell lines. Pflügers Arch 1998; 436: 69-74.
83. Cioffi DL, Barry C, Stevens T. Store-operated calcium entry channels in pulmonary endothelium: the emerging story of TRPCs and Orai1. Adv Exp Med Biol 2010; 661: 137-54.
84. 2+concentrations. Annu Rev Pharmacol Toxicol 2009; 49: 395-426.
85. Trebak M. Canonical transient receptor potential channels in disease: targets for novel drug therapy? Drug Discov Today 2006; 11: 924-30.
86. Tano JY, Smedlund K, Vazquez G. Endothelial TRPC3/6/7 proteins at the edge of cardiovascular disease. Cardiovasc Hematol Agents Med Chem 2010; 8: 76-86.
87. 2+entry in endothelial cells. Am J Physiol Cell Physiol 2009; 296: C403-13.
88. DeHaven WI, Jones BF, Petranka JG, et al. TRPC channels function independently of STIM1 and Orai1. J Physiol 2009; 587: 2275-98.
89. Patton AM, Kassis J, Doong H, Kohn EC. Calcium as a molecular target in angiogenesis. Curr Pharm Des 2003; 9: 543-51.
90. Hamdollah Zadeh MA, Glass CA, Magnussen A, Hancox JC, Bates DO. VEGF-mediated elevated intracellular calcium and angiogenesis in human microvascular endothelial cells in vitro are inhibited by dominant negative TRPC6. Microcirculation 2008; 15: 605-14.
91. Pupo E, Fiorio Pla A, Avanzato D, et al. Hydrogen sulfide promotes calcium signals and migration in tumor-derived endothelial cells. Free Radic Biol Med 2011; 51: 1765-73.
92. Gupta SK, Lysko PG, Pillarisetti K, Ohlstein E, Stadel JM. Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. J Biol Chem 1998; 273: 4282-7.
93. Kohn EC, Alessandro R, Spoonster J, Wersto RP, Liotta LA. Angiogenesis: role of calcium-mediated signal transduction. Proc Natl Acad Sci USA 1995; 92: 1307-11.
94. Kahl CR, Means AR. Regulation of cell cycle progression by calcium/ calmodulin-dependent pathways. Endocr Rev 2003; 24: 719-36.
95. 2+for cancer cell proliferation and survival. Nat Rev Cancer 2008; 8: 361-75.
96. Tomono M, Toyoshima K, Ito M, Amano H, Kiss Z. Inhibitors of calcineurin block expression of cyclins A and E induced by fibroblast growth factor in Swiss 3T3 fibroblasts. Arch Biochem Biophys 1998; 353: 374-8.
97. Madgwick S, Levasseur M, Jones KT. Calmodulin-dependent protein kinase II, and not protein kinase C, is sufficient for triggering cell-cycle resumption in mammalian eggs. J Cell Sci 2005; 118: 3849-59.
98. 2+signaling. Cell Mol Life Sci 2005; 62: 2405-13.
99. El Boustany C, Bidaux G, Enfissi A, Delcourt P, Prevarskaya N, Capiod T. Capacitative calcium entry and transient receptor potential canonical 6 expression control human hepatoma cell proliferation. Hepatology 2008; 47: 2068-77.
100. Glassford J, Soeiro I, Skarell SM, et al. BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells. Oncogene 2003; 22: 2248-59.
101. Hou MF, Kuo HC, Li JH, et al. Orai1/CRACM1 overexpression suppresses cell proliferation via attenuation of the store-operated calcium influx-mediated signalling pathway in A549 lung cancer cells. Biochim Biophys Acta 2011; doi:10.1016/j.bbagen.2011.07.001.
102. 2+source-dependent transcription of CRE-containing genes in vascular smooth muscle. Am J Physiol Heart Circ Physiol 2006; 291: H97-105.
103. 2+entry via TRPC channels is necessary for thrombin-induced NF-kappaB activation in endothelial cells through AMP-activated protein kinase and protein kinase Cdelta. J Biol Chem 2009; 284: 563-74.
104. Joyce D, Albanese C, Steer J, Fu M, Bouzahzah B, Pestell RG. NFkappaB and cell-cycle regulation: the cyclin connection. Cytokine Growth Factor Rev 2001; 12: 73-90.
105. Dupont G, Combettes L, Bird GS, Putney JW. Calcium oscillations. Cold Spring Harb Perspect Biol 2011; 3: 1-18.
106. 2+oscillation frequency regulates agonist-stimulated gene expression in vascular endothelial cells. J Cell Sci 2008; 121: 2511-18.
107. Pettit EJ, Fay FS. Cytosolic free calcium and the cytoskeleton in the control of leukocyte chemotaxis. Physiol Rev 1998; 78: 949-67.
108. Prevarskaya N, Skryma R, Shuba Y. Calcium in tumour metastasis: new roles for known actors. Nat Rev Cancer 2011; 1: 609-18.
109. Wei C, Wang X, Chen M, Ouyang K, Song LS, Cheng H. Calcium flickers steer cell migration. Nature 2009; 457: 901-5.
110. 2+mobilizing properties in migrating endothelial cells. Am J Physiol Heart Circ Physiol 2001; 281: H745-54.
111. Ridley AJ, Schwartz MA, Burridge K, et al. Cell migration: integrating signals from front to back. Science 2003; 302: 1704-9.
112. 2+oscillations in primary bone marrow stromal cells. J Cell Physiol 2006; 206: 664-71.
113. 2+activity in human cardiac fibroblasts. J Cell Physiol 2010; 223: 68-75.
114. Hu R, He ML, Hu H, et al. Characterization of calcium signaling pathways in human preadipocytes. J Cell Physiol 2009; 220: 765-70.
115. Kawano S, Otsu K, Kuruma A, et al. ATP autocrine/paracrine signaling induces calcium oscillations and NFAT activation in human mesenchymal stem cells. Cell Calcium 2006; 39: 313-24.
116. Kong H, Fan Y, Xie J, et al. AQP4 knockout impairs proliferation, migration and neuronal differentiation of adult neural stem cells. J Cell Sci 2003; 121: 4029-36.
117. Ferreira-Martins J, Rondon-Clavo C, Tugal D, et al. Spontaneous calcium oscillations regulate human cardiac progenitor cell growth. Circ Res 2009; 105: 764-74.
118. Horsley V, Pavlath GK. NFAT: ubiquitous regulator of cell differentiation and adaptation. J Cell Biol 2002; 156: 771-4.
119. 2+oscillation via RhoA pathway in stem cells. J Cell Physiol 2009; 218: 285-93.
120. Ciccolini F, Collins TJ, Sudhoelter J, Lipp P, Berridge MJ, Bootman MD. Local and global spontaneous calcium events regulate neurite outgrowth and onset of GABAergic phenotype during neural precursor differentiation. J Neurosci 2003; 23: 103-11.
121. Muller-Borer BJ, Cascio WE, Esch GL, et al. Mechanisms controlling the acquisition of a cardiac phenotype by liver stem cells. Proc Natl Acad Sci USA 2007; 104: 3877-82.
122. Sun S, Liu Y, Lipsky S, Cho M. Physical manipulation of calcium oscillations facilitates osteodifferentiation of human mesenchymal stem cells. FASEB J 2007; 21: 1472-80.
123. Weidt C, Niggemann B, Kasenda B, Drell TL, Zänker KS, Dittmar T. Stem cell migration: a quintessential stepping stone to successful therapy. Curr Stem Cell Res Ther; 2: 89-103.
124. +hematopoietic stem and progenitor cells. Stem Cells Dev 2007; 16: 827-36.
125. Brenner S, Whiting-Theobald N, Kawai T, et al. CXCR4-transgene expression significantly improves marrow engraftment of cultured hematopoietic stem cells. Stem Cells 2004; 22: 1128-33.
126. Maeng YS, Choi HJ, Kwon JY, et al. Endothelial progenitor cell homing: prominent role of the IGF2-IGF2R-PLCbeta2 axis. Blood 2009; 113: 233-43.
127. 2+entry is expressed in human endothelial progenitor cells. Stem Cells Dev 2010; 19: 1967-81.
128. Kuang CY, Yu Y, Guo RW, et al. Silencing stromal interaction molecule 1 by RNA interference inhibits the proliferation and migration of endothelial progenitor cells. Biochem Biophys Res Commun 2010; 398: 315-20.
129. Kuang CY, Yu Y, Wang K, Qian DH, Den MY, Huang L. Knockdown of transient receptor potential canonical-1 reduces the proliferation and migration of endothelial progenitor cells. Stem Cells Dev 2011; doi:10.1089/scd.2011.0027.
130. Shi Y, Song M, Guo R, Wang H, Gao P, Shi W, Huang L. Knockdown of stromal interaction molecule 1 attenuates hepatocyte growth factor-induced endothelial progenitor cell proliferation. Exp Biol Med 2010; 235: 317-25.
131. Ong HL, Ambudkar IS. The dynamic complexity of the TRPC1 channelosome. Channels 2011; http://dx.doi.org/10.4161/chan. 5.5.16471.
132. Rabbany SY, Heissig B, Hattori K, Rafii S. Molecular pathways regulating mobilization of marrow-derived stem cells for tissue revascularization. Trends Mol Med 2003; 9: 109-17.
133. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669-76.
134. 2+concentration. Stem Cells 2011; doi: 10.1002/stem.734.
135. Skupin A, Falcke M. Statistical properties and information content of calcium oscillations. Genome Inform 2007; 18: 44-53.
136. 2+oscillate: By chance or by the clock? Biophys J 2008; 94: 2404-11.
137. 2+-operated transcriptional networks: Molecular mechanisms and in vivo models. Physiol Rev 2008; 88: 421-49.
138. Dolmetsch RE, Xu K, Lewis RS. Calcium oscillations increase the efficiency and specificity of gene expression. Nature 1998; 392: 933-6.
139. Skupin A, Kettenmann H, Falcke M. Calcium signals driven by single channel noise. PLoS Comput Biol 2010; 6: 1-13.
140. 2+oscillations through the spatial signature drives gene expression. Curr Biol 2009; 19: 853-8.
141. Eggermann J, Kliche S, Jarmy J, et al. Endothelial progenitor cell culture and differentiation in vitro: a methodological comparison using human umbilical cord blood. Cardiov Res 2009; 58: 478-86.
142. 2+transport. Nat Rev Cancer 2007; 7: 519-30.
143. Askari AT, Penn MS. Targeted gene therapy for the treatment of cardiac dysfunction. Semin Thorac Cardiovasc Surg 2002; 14: 167-77.
144. Iwaguro H, Yamaguchi J, Kalka C, et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002; 105: 732-8.
145. Meng QY, Li XQ, Yu XB, Lei FR, Jiang K, Li CY. Transplantation of VEGF165-gene-transfected endothelial progenitor cells in the treatment of chronic venous thrombosis in rats. Chin Med J 2010 123: 471-7.
146. 2+(CRAC) channels by stromal interaction molecule 1 (Stim1). Proc Natl Acad Sci USA 2010; 108: 13299-304.
147. Hou MF, Kuo HC, Li JH, et al. Orai1/CRACM1 overexpression suppresses cell proliferation via attenuation of the store-operated calcium influx-mediated signalling pathway in A549 lung cancer cells. Biochim Biophys Acta 2011; doi:10.1016/j.bbagen. 2011.07.001.
148. Soboloff J, Spassova MA, Tang XD, Hewavitharana T, Xu W, Gill DL. Orai1 and STIM reconstitute store-operated calcium channel function. J Biol Chem 2006; 281: 20661-65.
149. Hewavitharana T, Deng X, Soboloff J, Gill DL. Role of Stim and Orai proteins in the store-operated calcium signaling pathway. Cell Calcium 2007; 42: 173-82.
150. 2+entry associated with metabolic syndrome and coronary atherosclerosis. Cardiovasc Res 2010; 85: 631-40.
151. 2+handling of smooth muscle cells in aorta of apolipoprotein Edeficient mice before development of atherosclerotic lesions. Cell Calcium 2007; 41: 295-302.
152. Bishara NB, Ding H. Glucose enhances expression of TRPC1 and calcium entry in endothelial cells. Am J Physiol Heart Circ Physiol 2010; 298: H171-8.
153. Levi F, Ferlay J, Galeone C, et al. The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int 2008; 101: 949-58.
154. Bhatt RS, Zurita AJ, O'Neill A, et al. Increased mobilisation of circulating endothelial progenitors in von Hippel-Lindau disease and renal cell carcinoma. Br J Cancer 2011; 105: 112-7.
155. Namdarian B, Tan KVS, Fankhauser MJ, et al. Circulating endothelial cells and progenitors: potential biomarkers of renal cell carcinoma. BJU Int 2010; 106: 1081-7.
156. Hill PA. Recipient origin of vasculature in renal cell carcinoma in a kidney allograft. Pathology 2010; 42: 479-80.
157. Dutcher JP, Leon L, Manola J, Friedland DM, Roth B, Wilding G. Phase II study of carboxyamidotriazole in patients with advanced renal cell carcinoma refractory to immunotherapy-E4896, an Eastern Cooperative Oncology Group Study. Cancer 2005; 104: 2392-9.
158. Wu YG, Palad AJ, Wasilenko WJ, et al. Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazole. Clin Cancer Res 1997; 3: 1915-21.
159. Jaffe LF. A calcium-based theory of carcinogenesis. Adv Cancer Res 2005; 94:231-63.
160. Sweeney ZK, Minatti A, Button DC, Patrick S. Small-molecule inhibitors of store-operated calcium entry. Curr Med Chem 2009; 4: 706-18.
161. Weinberg BD, Blanco E, Gao J. Polymer implants for intratumoral drug delivery and cancer therapy. J Pharm Sci 2008; 97: 1681-702.
162. Liu CC, Shen Z, Kung HF, Lin MC. Cancer gene therapy targeting angiogenesis: an updated review. World J Gastroenterol 2006; 12: 6941-8.
163. Zhang W, Halligan KE, Zhang X, et al. Orai1-mediated ICRAC is essential for neointima formation after vascular injury. Circ Res 2011; 9: 534-42.
164. Aubart FC, Sassi Y, Coulombe A, et al. RNA interference targeting STIM1 suppresses vascular smooth muscle cell proliferation and neointima formation in the rat. Mol Ther 2009; 17: 455-62.
165. Bussolati B, Deregibus MC, Camussi G. Characterization of molecular and functional alterations of tumor endothelial cells to design anti-angiogenic strategies. Curr Vasc Pharmacol 2010; 8: 220-32.
166. Fiorio Pla A, Ong HL, Cheng KT, et al. TRPV4 mediates tumorderived endothelial cell migration via arachidonic acid-activated actin remodeling. Oncogene 2011; 31: 200-12.
167. Prevarskaya N, Skryma R, ShubaY. Ion channels and the hallmarks of cancer. Trends Mol Med 2010; 16: 107-21.
168. Putney JW. The physiological function of store-operated calcium entry. Neurochem Res 2011; 36: 1157-65.
169. Roberts-Thomson SJ, Peters AA, Grice DM, Monteith G.R. ORAImediated calcium entry: mechanism and roles, diseases and pharmacology. Pharmacol Ther 2010; 127: 121-30.
170. 2+uptake: inhibition by salicylate. J Physiol 2006; 571: 57-73.
171. 2+store depletion in endothelial cells. Cell Calcium 2008; 43: 83-94.
172. Tano Y, Smedlund K, Vazquez G. Endothelial TRPC3/6/7 proteins at the edge of cardiovascular disease. Cardiovasc. Hematol Agents Med Chem 2010; 8: 76-86.
173. Putney JW. Pharmacology of store-operated calcium channels. Mol Interv 2010; 10: 209-18.
174. 2+entry via STIM proteins. Cell Calcium 2010, 47: 1-10.
175. 2+signaling in injured in situ endothelium of rat aorta. Cell Calcium 2008: 44: 298-309.
176. 2+influx and cytokine production by facilitating transient receptor potential melastatin 4 channel activity. Mol Pharmacol 2006; 69: 1413-20.
177. He LP, Hewavitharana T, Soboloff J, Spassova MA, Gill DL. A functional link between store-operated and TRPC channels revealed by the 3,5-bis(trifluoromethyl)pyrazole derivative, BTP2. J Biol Chem 2005; 280: 10997-1006.
178. 2+channels inhibits T cell cytokine production and T-box transcription factor T-bet in inflammatory bowel disease. J Immunol 2009; 183: 3454-462.
179. Beech DJ. Orai1 calcium channels in the vasculature. Pflugers Arch 2012; 463: 635-47.
180. 2+uptake: inhibition by salicylate. J Physiol 2006; 571: 57-73.
181. Rüegg C, Dormond O. Suppression of tumor angiogenesis by nonsteroidal anti-inflammatory drugs: a new function for old drugs. ScientificWorldJournal 2001; 1: 808-11.
182. 2+-dependent inactivation of calcium release-activated calcium/Orai channels normally prevented by mitochondria. J Biol Chem 2001; 286: 16186-96.